Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
KR$66.06-0.71(-1.06%)Tempo Fuels Eaters Further with New Line of Protein Max Meals To meet wellness-minded customers' growing demand for more protein, prepared meal delivery service Tempo is launching a new lineup of Protein Max...[9:33:00 AM ET]SXLXF$0.040.00(0.00%)SLAM Exploration to Attend the 52nd Annual New Orleans Investment Conference[9:30:00 AM ET]ONCY$0.48+0.01(+1.90%)Oncolytics Biotech® Reports Strong Durability and Survival Data in Anal Cancer, Positioning Pelareorep as Potential Backbone Immunotherapy Across HPV-Driven Cancers[9:30:00 AM ET]UNIT$4.98+0.13(+2.68%)Uniti Wholesale Expands Connectivity at Nine Data Centers, Bringing New Capacity to Key Markets[9:30:00 AM ET]CHRS$1.02+0.00(+0.50%)Coherus to Participate in Upcoming Investor Conferences[9:30:00 AM ET]HYFM$0.74-0.11(-12.96%)Hydrofarm Holdings Group Announces Termination of $109 Million Senior Secured Term Loan in Connection with Pricing of Aggregate $8.3 Million Registered Direct Offering and Concurrent Private Placement[9:29:58 AM ET]NVEC$77.83+2.27(+3.00%)NVE Corporation (NVEC) Faces Investor Scrutiny Amid Revenue Pull-Forward– HBSS[9:25:34 AM ET]DFNS$3.67-0.20(-5.23%)T3 Defense Enters Agreement to Acquire KeepZone AI[9:25:00 AM ET]DBGI$1.170.00(0.00%)DBGI Staying Public for Now but Continues to Review Inbound Interest Driven by Digital Marketing Success and Accelerating Government Contracts[9:23:00 AM ET]ONGRF$0.36-0.00(-0.55%)ONGold Closes Upsized $9.0 Million LIFE Financing[9:23:00 AM ET]

ICCM · NASDAQ

IceCure Medical Ltd

$1.04 +0.01 (+0.97%)

Company overview

IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers the ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Market cap
$2.3M
Employees
64
Headquarters
Caesarea
Website
icecure-medical.com
CEO
Eyal Shamir
Listed
August 26, 2021
P/E
-4.47
Dividend yield
0.00%

Company financials

Revenue
$3.6M
Gross profit
$1.3M
Operating income
-$29.8M
EBITDA
-$15.4M
Net income
-$15.7M
EPS
-$0.23
Total assets
$13.3M
Total debt
$139,000
Gross margin
36.55%
Net margin
-441.60%
Earnings yield
-22.38%

Revenue segmentation

By product (FY 2025)

No product segmentation.

By region (FY 2025)

Showing FY 2025

Price chart

0.612.995.387.7710.15
ICCM 1D NASDAQ O1.00H1.04L0.97C1.03+0.02 (+1.98%)Vol25.30K

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
Ticker Type Headline Source Published
ICCMIceCure Medical Ltd Press release IceCure Successfully Completes First Cryoablation Treatment in Its ChoICE Post-Marketing Study for Breast Cancer Cryoablation IceCure Medical Ltd. PR Newswire
ICCMIceCure Medical Ltd Press release IceCure Enrolls First Patients in Its FDA-Approved Study for ProSense® Breast Cancer Cryoablation at Two U.S. Sites IceCure Medical Ltd. PR Newswire
ICCMIceCure Medical Ltd Stock news Nexalin Technology (NASDAQ:NXL) vs. IceCure Medical (NASDAQ:ICCM) Financial Analysis Defense World
ICCMIceCure Medical Ltd Press release IceCure Highlights Clinical Data and Strong Physician Engagement for ProSense® Breast Cancer Cryoablation at EUSOBI 2026 IceCure Medical Ltd. PR Newswire
ICCMIceCure Medical Ltd Press release IceCure Expands ProSense® ChoICE Study for Low-Risk Breast Cancer adding Legacy Health in Portland, OR as U.S. Clinical Site PRNewsWire
ICCMIceCure Medical Ltd Stock news Reviewing IceCure Medical (NASDAQ:ICCM) & Precision Optics (NASDAQ:POCI) Defense World
ICCMIceCure Medical Ltd Stock news IceCure Secures China NMPA Approval for ProSense Cryoablation System Zacks Investment Research
ICCMIceCure Medical Ltd Press release IceCure Medical Receives Regulatory Approval to Market ProSense® in China PRNewsWire
ICCMIceCure Medical Ltd Press release IceCure Signs Exclusive Distribution Agreement for ProSense® Cryoablation Systems in the Netherlands PRNewsWire
ICCMIceCure Medical Ltd Press release West Cancer Center Receives IRB Approval to Commence IceCure's ChoICE Study for Breast Cancer Cryoablation PRNewsWire
ICCMIceCure Medical Ltd Press release IceCure Highlights Two New Peer-Reviewed Publications Supporting Cryoablation in Breast Cancer Treatment De-Escalation PRNewsWire
ICCMIceCure Medical Ltd Stock news IceCure Medical Ltd (ICCM) Q2 2026 Earnings Call Transcript Seeking Alpha
ICCMIceCure Medical Ltd Press release IceCure Reports its Financial Results for the First Half of 2026 with 45% Revenue Growth Year-Over-Year PRNewsWire
ICCMIceCure Medical Ltd Press release IceCure Medical Adds Adventist Health as U.S. Clinical Site for its Post-Marketing "ChoICE" Study for Low-Risk Breast Cancer Cryoablation Treatment PRNewsWire
ICCMIceCure Medical Ltd Press release IceCure Medical to Report First Half 2026 Financial and Operating Results on August 12, 2026 PRNewsWire
ICCMIceCure Medical Ltd Press release IceCure Medical Kicks Off its Post-Marketing "ChoICE" Study for the Low-Risk Breast Cancer Treatment at First U.S Clinical Site PRNewsWire
ICCMIceCure Medical Ltd Press release IceCure Highlights Expanding Commercial Adoption of ProSense™ Cryoablation in Brazil Following FDA Clearance for Breast Cancer PRNewsWire
ICCMIceCure Medical Ltd Press release IceCure's ProSense® Reports Nearly 90% Recurrence-Free Rate for Cryoablation of Kidney Cancer: Data Presented at ECIO 2026 and First-Ever Breast Cryoablation Master Class Overbooked PRNewsWire
ICCMIceCure Medical Ltd Press release IceCure Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement PRNewsWire
ICCMIceCure Medical Ltd Stock news IceCure Medical Ltd (ICCM) Q1 2026 Earnings Call Transcript Seeking Alpha
See more
FAQ

Questions about IceCure Medical Ltd

What does IceCure Medical Ltd do?
IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers the ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
What is ICCM's market cap?
IceCure Medical Ltd (ICCM) is a listed stock with a live quote. The latest market cap on this page is $2.3M.
Where is IceCure Medical Ltd headquartered?
IceCure Medical Ltd is headquartered in Caesarea.
How do I get ICCM news from the API?
Call GET /v1/news?tickers=ICCM. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does ICCM news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for ICCM, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the ICCM price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 1,000 REST requests a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs